These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 16780264
1. [Bone marrow isolated micrometastases of non-small cell lung cancer]. Dancewicz M, Kowalewski J, Sir J, Pepliński J, Jezierska A. Pol Merkur Lekarski; 2006 Mar; 20(117):315-7. PubMed ID: 16780264 [Abstract] [Full Text] [Related]
3. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ohgami A, Mitsudomi T, Sugio K, Tsuda T, Oyama T, Nishida K, Osaki T, Yasumoto K. Ann Thorac Surg; 1997 Aug; 64(2):363-7. PubMed ID: 9262576 [Abstract] [Full Text] [Related]
4. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg O, Thetter O, Riethmüller G. Cancer Res; 1993 Mar 01; 53(5):1027-31. PubMed ID: 7679945 [Abstract] [Full Text] [Related]
5. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators. Hofmann T, Riesenberg R, Buchner A, Zimmermann W, Hofstetter A, Oberneder R. J Urol; 2003 Apr 01; 169(4):1303-7. PubMed ID: 12629348 [Abstract] [Full Text] [Related]
6. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma. Buchner A, Riesenberg R, Kotter I, Crispin A, Hofstetter A, Oberneder R. J Urol; 2003 Nov 01; 170(5):1747-51. PubMed ID: 14532768 [Abstract] [Full Text] [Related]
7. Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumour recurrence and prognosis. Hsu CP SL, Chen CY, Kwang PC, Miao J, Hsia JY, Shai SE. Eur J Surg Oncol; 2000 Nov 01; 26(7):691-5. PubMed ID: 11078616 [Abstract] [Full Text] [Related]
8. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer? Ruffato A, Mattioli S, Pileri S, Daddi N, D'Ovidio F, Pilotti V, Tazzari P. Eur J Cardiothorac Surg; 2009 Mar 01; 35(3):463-8. PubMed ID: 19150243 [Abstract] [Full Text] [Related]
9. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance. Rena O, Carsana L, Cristina S, Papalia E, Massera F, Errico L, Bozzola C, Casadio C. Eur J Cardiothorac Surg; 2007 Dec 01; 32(6):863-7. PubMed ID: 17936004 [Abstract] [Full Text] [Related]
10. Clinical significance of bone marrow microinvolvement in nonsmall cell lung carcinoma. Hsu CP, Shai SE, Hsia JY, Chen CY. Cancer; 2004 Feb 15; 100(4):794-800. PubMed ID: 14770436 [Abstract] [Full Text] [Related]
11. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy? Weckermann D, Wawroschek F, Krawczak G, Haude KH, Harzmann R. Urol Res; 1999 Oct 15; 27(5):285-90. PubMed ID: 10644227 [Abstract] [Full Text] [Related]
12. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer]. Passlick B, Kubuschok B, Izbicki JR, Thetter O, Pantel K. Pneumologie; 2000 Aug 15; 54(8):355-60. PubMed ID: 11008478 [Abstract] [Full Text] [Related]
13. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma. Buchner A, Riesenberg R, Kotter I, Hofstetter A, Stief C, Oberneder R. Cancer; 2006 Apr 01; 106(7):1514-20. PubMed ID: 16518813 [Abstract] [Full Text] [Related]
14. [The prognostic value of cytokeratin 19 expression in non-small cell lung cancer]. Kosacka M, Jankowska R. Pneumonol Alergol Pol; 2007 Apr 01; 75(4):317-23. PubMed ID: 18080980 [Abstract] [Full Text] [Related]
15. [Clinical pathological study on nodal micrometastases of non-small-cell lung cancer]. Wang YX, Chu XY, Sun YE, Wang ZB, Li XH, Zhang GK. Zhonghua Wai Ke Za Zhi; 2007 Jan 15; 45(2):114-7. PubMed ID: 17418040 [Abstract] [Full Text] [Related]
16. Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. Masuda TA, Kataoka A, Ohno S, Murakami S, Mimori K, Utsunomiya T, Inoue H, Tsutsui S, Kinoshita J, Masuda N, Moriyama N, Mori M. Int J Oncol; 2005 Mar 15; 26(3):721-30. PubMed ID: 15703829 [Abstract] [Full Text] [Related]
17. Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients. Litle VR, Warren RS, Moore D, Pallavicini MG. Cancer; 1997 May 01; 79(9):1664-70. PubMed ID: 9128980 [Abstract] [Full Text] [Related]
18. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Tamas EF, Epstein JI. Am J Surg Pathol; 2007 Mar 01; 31(3):390-7. PubMed ID: 17325480 [Abstract] [Full Text] [Related]
19. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. Z'graggen K, Centeno BA, Fernandez-del Castillo C, Jimenez RE, Werner J, Warshaw AL. Surgery; 2001 May 01; 129(5):537-46. PubMed ID: 11331445 [Abstract] [Full Text] [Related]
20. Micrometastases in bone marrow of patients with suspected pancreatic and ampullary cancer. van Heek NT, Tascilar M, van Beekveld JL, Drillenburg P, Offerhaus GJ, Gouma DJ. Eur J Surg Oncol; 2001 Dec 01; 27(8):740-5. PubMed ID: 11735170 [Abstract] [Full Text] [Related] Page: [Next] [New Search]